# OncoSafeRx - Strategic Acquisition Pitch Deck

## Slide 1: Cover
**OncoSafeRx**
*AI-Powered Clinical Decision Support for Oncology*

**Strategic Acquisition Opportunity**
- Modern pharmacogenomics platform
- FDA-integrated drug interaction engine  
- Ready for immediate EHR deployment

---

## Slide 2: The $40B Problem
### Healthcare's Deadly Drug Interaction Crisis

**125,000 deaths annually** from preventable drug interactions
- **$40B+ in healthcare costs** from medication errors
- **#4 leading cause** of death in hospitals
- **85% of oncologists** lack pharmacogenomics decision support

**The Gap:** Existing solutions (Lexicomp, Epocrates) lack:
- Real-time pharmacogenomic insights
- Oncology-specific protocols  
- Modern AI-driven recommendations

---

## Slide 3: Market Opportunity
### Growing Healthcare IT Markets

**Clinical Decision Support Systems**
- **$3.89B market by 2030** (9.6% CAGR)
- **6.1x average acquisition multiple** in healthcare IT

**Pharmacogenomics Market**  
- **$12.8B by 2033** (9.7% CAGR)
- **Recent acquisition:** YouScript sold for $79M

**Target Segments:**
- 6,000+ oncology practices in US
- 600+ cancer centers 
- 200+ health systems with oncology programs

---

## Slide 4: Solution Overview
### OncoSafeRx Platform

**Core Capabilities:**
- ✅ **Real-time drug interaction screening** via FDA RxNorm
- ✅ **Pharmacogenomic recommendations** using CPIC guidelines
- ✅ **Oncology-specific protocols** for cancer treatments
- ✅ **EHR-ready APIs** for Epic, Cerner, Allscripts integration

**Differentiators:**
- Modern React/Node.js architecture (AI-ready)
- Real-time analytics and usage tracking
- Comprehensive test suite (78+ test files)
- Production-deployed on oncosaferx.com

---

## Slide 5: Technology Stack
### Built for Enterprise Integration

**Frontend:** React + TypeScript + Modern UI
**Backend:** Node.js + Express + PostgreSQL  
**Database:** Supabase (production-ready)
**APIs:** FDA RxNorm, DailyMed, CPIC integrated
**Infrastructure:** Netlify + Docker + Kubernetes-ready

**Key Technical Assets:**
- FDA-compliant data integration
- HIPAA-ready architecture
- Real-time visitor analytics
- Multi-tenant SaaS design
- Comprehensive API documentation

---

## Slide 6: Competitive Landscape
### Strategic Positioning

| Platform | Focus | Integration | AI-Ready | Oncology-Specific |
|----------|-------|-------------|----------|-------------------|
| **OncoSafeRx** | ✅ Oncology + PGx | ✅ Modern APIs | ✅ Built for AI | ✅ Cancer protocols |
| Lexicomp | General drug info | Legacy integration | ❌ Limited | ❌ Generic |
| Epocrates | General prescribing | Mobile-first | ❌ Basic | ❌ Generic |
| YouScript | PGx testing | Limited EHR | ❌ Basic | ❌ All conditions |

**Competitive Advantages:**
- Only platform combining oncology + pharmacogenomics
- Modern architecture vs. legacy systems
- Real-time analytics and insights
- Ready for AI/ML enhancement

---

## Slide 7: Business Model & Revenue
### Scalable SaaS with Multiple Revenue Streams

**Primary Revenue:**
- **Enterprise SaaS:** $50-200K annually per health system
- **Practice licenses:** $1,200-3,600 annually per provider  
- **API calls:** $0.10 per drug interaction check

**Revenue Projections:**
- **Year 1:** $120K ARR (10 practices)
- **Year 2:** $600K ARR (50 practices, 2 health systems)  
- **Year 3:** $2.4M ARR (enterprise + API partnerships)

**Unit Economics:**
- Customer LTV: $25K-150K
- CAC: $2K-8K  
- Gross margin: 85%+

---

## Slide 8: Go-to-Market Strategy
### Three-Phase Acquisition Strategy

**Phase 1: Pilot Revenue (Next 90 days)**
- 5 oncology practice pilots @ $2K/month
- Target: $10K MRR proof of concept

**Phase 2: Health System Expansion (6 months)**  
- 2-3 regional health system deployments
- Target: $50K MRR enterprise revenue

**Phase 3: EHR Partnership (12 months)**
- White-label integration with Epic/Cerner
- Target: $200K+ MRR through channel partners

---

## Slide 9: Strategic Acquisition Value
### Perfect Fit for Healthcare IT Leaders

**For Epic/Cerner:**
- Immediate oncology differentiation
- Modern API architecture  
- Pharmacogenomics capability gap

**For Wolters Kluwer:**
- Complement to Lexicomp portfolio
- Oncology market expansion
- AI/analytics enhancement

**For McKesson/Cardinal:**
- Pharmacy workflow integration
- Clinical decision support expansion
- Revenue cycle optimization

---

## Slide 10: Financial Projections
### Path to $10M+ ARR

**Revenue Model:**
```
Year 1: $120K ARR (10 practices × $1K/month)
Year 2: $600K ARR (50 practices + 2 health systems)  
Year 3: $2.4M ARR (enterprise deals + API revenue)
Year 4: $6M ARR (EHR partnerships + scale)
Year 5: $12M ARR (national deployment)
```

**Key Metrics:**
- Monthly churn: <5%
- Net revenue retention: 120%+
- Gross margin: 85%
- Sales efficiency: $3 ARR per $1 CAC

---

## Slide 11: Investment Requirements
### Funding for Scale

**Total Funding Need: $2-3M**

**Use of Funds:**
- **Sales & Marketing (40%):** $800K-1.2M
  - Sales team (2-3 reps)
  - Marketing automation
  - Conference presence

- **Product Development (35%):** $700K-1M  
  - AI/ML capabilities
  - EHR integrations
  - Mobile applications

- **Compliance & Security (15%):** $300-450K
  - HIPAA audit and certification
  - Security penetration testing
  - Regulatory compliance

- **Operations (10%):** $200-350K
  - Infrastructure scaling
  - Support team
  - Legal and accounting

---

## Slide 12: Exit Strategy & Valuation
### Strategic Acquisition Timeline

**Current Valuation: $1-3M**
- Technology asset + FDA integration
- Market positioning + regulatory moat

**12-Month Target: $8-15M** 
- $1M+ ARR × 8-15x healthcare IT multiple
- Strategic premium for oncology focus

**Acquisition Comps:**
- YouScript: $79M (pharmacogenomics)
- HealthEdge: $3.2B (health IT platform)
- EvidenceCare: Strategic acquisition 2025

**Target Acquirers:**
1. **Epic Systems** - EHR market leader
2. **Wolters Kluwer** - Clinical decision support
3. **McKesson** - Healthcare technology & pharmacy
4. **Private Equity** - Healthcare IT rollup

---

## Slide 13: Team & Advisory
### Experienced Healthcare Technology Leadership

**Founder:** Gautam Dogra
- Healthcare technology expertise
- Full-stack development background
- Regulatory compliance experience

**Advisory Board Needs:**
- Chief Medical Officer (Oncology)
- VP Sales (Healthcare IT)  
- Regulatory Affairs (FDA/HIPAA)
- Clinical Pharmacist (Pharmacogenomics)

**Investment in Team:**
- Hire VP Sales (healthcare IT experience)
- Add clinical advisory board
- Expand engineering team

---

## Slide 14: Demo & Next Steps
### Live Platform Demonstration

**Demo Highlights:**
1. **Drug interaction screening** for cancer treatments
2. **Pharmacogenomic recommendations** based on patient genetics
3. **Clinical decision support** for oncology protocols
4. **EHR integration** mockup with Epic workflow
5. **Analytics dashboard** showing usage and outcomes

**Next Steps:**
1. **Pilot program** with interested health systems
2. **Due diligence** technical and business review
3. **Term sheet** discussion for strategic partnership/acquisition
4. **Integration planning** for immediate value creation

---

## Slide 15: Contact & Call to Action

**OncoSafeRx Strategic Partnership**

**Contact:**
- **Website:** oncosaferx.com
- **Email:** partnerships@oncosaferx.com
- **Demo:** Schedule technical demonstration

**Value Proposition:**
- Immediate revenue opportunity in oncology market
- Modern technology stack ready for AI integration
- Regulatory compliance and FDA data integration complete
- Strategic fit for EHR and clinical decision support leaders

**Call to Action:**
*Ready to transform oncology clinical decision support together.*

---

## Appendix: Technical Architecture

**System Architecture:**
- Microservices design with API-first approach
- Real-time analytics and visitor tracking
- Scalable database architecture (Supabase/PostgreSQL)
- Container-ready deployment (Docker/Kubernetes)
- Comprehensive monitoring and observability

**Security & Compliance:**
- HIPAA-ready infrastructure design
- End-to-end encryption for patient data
- Role-based access controls
- Audit logging and compliance reporting
- SOC 2 Type II preparation underway

**Integration Capabilities:**
- RESTful APIs for EHR integration
- HL7 FHIR compatibility planning
- Real-time data synchronization
- Webhook support for event-driven workflows
- SDK development for rapid integration